Auspherix Limited (UK)
Stevenage Bioscience Catalyst
Gunnels Wood Road
Auspherix is a pre-clinical stage anti-infectives company initially founded in late 2013 based on discoveries made at the ithree institute at the University of Technology Sydney (UTS) by Professor Ian Charles and Dr Dagmar Alber.
Auspherix is now located in the UK and operates from offices and research labs in the Stevenage Bioscience Catalyst facility. The Company is building a world class microbiology team to progress its R&D programmes based on its proprietary antibacterials, which have a unique profile. Its compound series show activity against a broad range of multidrug resistant (MDR) important Gram-negative and Gram-positive bacterial infections.
CEO: Dr. Neil Miller
COO: Grant Hawthorne
CSO: Dr. Richard Rutter
Head of Chemistry: Dr. Paul King
Please click here for Auspherix's job opportunities.